Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | CA1 | P00915 | 4/20 | 0.40 |
| ▸ | CA2 | P00918 | 4/20 | 0.40 |
| ▸ | CA12 | O43570 | 3/20 | 0.40 |
| ▸ | CA7 | P43166 | 3/20 | 0.40 |
| ▸ | CA9 | Q16790 | 3/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.40 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.39 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | METTL3 | Q86U44 | 1/20 | 0.36 |
| ▸ | BAZ2B | Q9UIF8 | 1/20 | 0.36 |
| ▸ | BAZ2A | Q9UIF9 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.35 |
| ▸ | CASP1 | P29466 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7128463 | 0.84 | CA12 (0.44) | TSHRCA1CA2CA12CA7 | |
| SCHEMBL7134324 | 0.82 | TSHR (0.41) | TSHRCA1CA2CA12CA7 | |
| SCHEMBL7126939 | 0.80 | TSHR (0.53) | TSHRCA1CA2CA12CA7 | |
| SCHEMBL6752025 | 0.72 | POLB (0.45) | TSHRCA1CA2CA12CA7 | |
| SCHEMBL7128460 | 0.71 | CA12 (0.49) | TSHRCA1CA2CA12CA7 | |
| SCHEMBL27993113 | 0.71 | TSHR (0.55) | TSHRCA1CA2CA12CA7 | |
| SCHEMBL27259744 | 0.71 | CYP4F2 (0.55) | TSHRCA1CA2CA12CA7 | |
| SCHEMBL7132923 | 0.70 | TSHR (0.38) | TSHRHSD17B10ALDH1A1MEN1KMT2A | |
| SCHEMBL7127746 | 0.70 | TSHR (0.54) | TSHRCA1CA2CA12CA7 | |
| SCHEMBL7130122 | 0.70 | CA1 (0.51) | CA1CA2CA12CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6756343-B1 | CONTROLLING RICE PADDY FIELD WEEDS AT LOW DOSAGE DOSE; PLANT SAFENING | IDEMITSU KOSAN CO., LTD. (JP) | 2004-06-29 | — | — | US | disclosed |
| US-20040058957-A1 | Benzothiophene derivatives and herbicidal compositions containing the same | IDEMITSU KOSAN CO., LTD. (JP) | 2004-03-25 | — | — | US | disclosed |
| US-20040002425-A1 | Triketone derivatives and herbicides | IDEMITSU KOSAN CO., LTD. (JP) | 2004-01-01 | — | — | US | disclosed |
| CN-1350531-A | azole compounds and herbicidal compositions | IDEMITSU KOSAN CO (JP) | 2002-05-22 | — | — | CN | disclosed |
| EP-1182203-A1 | AZOLE COMPOUNDS AND HERBICIDE COMPOSITIONS | Idemitsu Kosan Co., Ltd. (JP) | 2002-02-27 | — | — | EP | disclosed |
| CN-1326452-A | Triketone derivatives and herbicides | IDEMITSU KOSAN CO (JP) | 2001-12-12 | — | — | CN | disclosed |
| EP-1120413-A1 | TRIKETONE DERIVATIVE AND HERBICIDE | IDEMITSU KOSAN COMPANY LIMITED (JP) | 2001-08-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040058957-A1 | Benzothiophene derivatives and herbicidal compositions containing the same | DDT, CYP4X1, BPNT1 | TSHR 1655/4885CA1 3006/4885CA2 2201/4885 |
| US-20040002425-A1 | Triketone derivatives and herbicides | SYMPK, STK36, STK32A | TSHR 1166/4885CA1 2942/4885CA2 2520/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.